FDA 483 - Dxn Pharmaceutical Sdn Bhd - March 06, 2026

DXN Pharmaceutical Sdn Bhd, a dietary supplement manufacturer, was inspected and cited for deficiencies in its master manufacturing records. The records failed to include complete descriptions of all packaging materials, specifically desiccant packets, for its dietary supplement products, indicating a lack of control over consistent packaging.